2025-2034 Smart Biopsy Devices Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Smart Biopsy Devices Industry Market Size Be by 2025?
The market for smart biopsy devices has seen significant growth in recent times. From $2.85 billion in 2024, it is expected to expand to $3.04 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. The historic growth can be attributed to factors such as the rise in cancer diagnoses, the preference for minimally invasive procedures, advancements in medical devices technology, and enhanced diagnostic accuracy.

What's the Long-Term Growth Forecast for the Smart Biopsy Devices Market Size Through 2029?
The market size for smart biopsy devices is slated for substantial expansion in the upcoming years, with an estimated valuation at $4.05 billion by 2029. This corresponds to a compound annual growth rate (CAGR) of 7.5%. This projected growth during the forecast period is linked to the expansion of personalized medicine, advancements in imaging technologies, increased reliance on biopsy for biomarker analysis, entry of new competitors in the market, and improvements in data connectivity. Significant trends for this forecast period include the usage of robotic-assisted biopsies, the adoption of AI in biopsy procedures, the creation of wireless biopsy tools, the proliferation of portable and handheld devices, and the incorporation of real-time guidance systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

What Are the Key Growth Drivers Fueling the Smart Biopsy Devices Market Expansion?
The anticipated increase in cancer incidents is set to boost the expansion of the smart biopsy devices market. Cancer, a diverse group of diseases that can develop in almost any organ or tissue, occurs when unusual cells multiply uncontrollably, exceeding their typical boundaries, and either metastasize to other organs or infiltrate nearby body parts. The mounting volume of cancer incidents amplifies the demand for accurate and concentrated tissue samples. This has catalyzed the development and enhancement of smart biopsy tools with superior molecular, imaging, and accuracy capabilities to assist in diagnosis and treatment preparation. For example, the World Health Organization, an Intergovernmental organization based in Switzerland, projected in January 2024 that over 35 million new cancer incidents will be reported by 2050. This marks a 77% surge from the estimated 20 million incidents and 9.7 million deaths documented in 2022. Thus, the escalating cancer incidents are facilitating the growth of the smart biopsy device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Are the Key Trends Driving Smart Biopsy Devices Market Growth?
Market leaders in the smart biopsy device industry are introducing novel products such as breast biopsy markers in an effort to boost the accuracy and efficiency of breast cancer diagnosis procedures. These markers are crafted to exactly identify the position of a tissue sample collected during a biopsy, assisting in outlining subsequent treatments and guaranteeing the appropriate area is scrutinized for potential cancerous growth. For example, in August 2022, Mammotome, an American medical devices firm, rolled out the Mammotome DualCore Dual Stage Core Biopsy System. This is a minimally invasive breast biopsy device that employs a dual-stage method to yield accurate, high-quality tissue specimens. It is frequently utilized in combination with ultrasound for a precise, safe, and effective diagnosis of breast cancer. This system can merge with cutting-edge breast biopsy markers, providing medical professionals with an exhaustive and inventive solution for ultrasound-guided breast biopsies.

How Is the Smart Biopsy Devices Market Segmented?
The smart biopsy devices market covered in this report is segmented -

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays
3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices
4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Which Companies Are Leading the Charge in Smart Biopsy Devices Market Innovation?
Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

Which Regions Are Leading the Global Smart Biopsy Devices Market in Revenue?
North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.